Chk2 Suppresses the Oncogenic Potential of DNA Replication-Associated DNA Damage
- 1 July 2008
- journal article
- research article
- Published by Elsevier in Molecular Cell
- Vol. 31 (1) , 21-32
- https://doi.org/10.1016/j.molcel.2008.04.028
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- Shaping Genetic Alterations in Human Cancer: The p53 Mutation ParadigmCancer Cell, 2007
- The carboxy terminus of NBS1 is required for induction of apoptosis by the MRE11 complexNature, 2007
- p21 delays tumor onset by preservation of chromosomal stabilityProceedings of the National Academy of Sciences, 2006
- Ser18 and 23 phosphorylation is required for p53-dependent apoptosis and tumor suppressionThe EMBO Journal, 2006
- ATM–Chk2–p53 activation prevents tumorigenesis at an expense of organ homeostasis upon Brca1 deficiencyThe EMBO Journal, 2006
- Activation of the DNA damage checkpoint and genomic instability in human precancerous lesionsNature, 2005
- DNA damage response as a candidate anti-cancer barrier in early human tumorigenesisNature, 2005
- Double Strand Break Metabolism and Cancer Susceptibility: Lessons from the Mre11 ComplexCell Cycle, 2004
- DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociationNature, 2003
- Atm selectively regulates distinct p53-dependent cell-cycle checkpoint and apoptotic pathwaysNature Genetics, 1997